Catalyst Wire Dossier Catalyst Wire Dossier

HypoTHermosol FRS

HTS-FRS · Corestemchemon, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HypoTHermosol FRS, covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS [Phase 1]

See pricing